All Activity

Positive site, where did u come up with the information on this posting? I'm pleased I discovered it though, ill be checking back soon to find out what additional posts you include. Hiddenfashion

Federal officials are calling marijuana a “deadly” drug—touting their efforts to seize it and other illegal substances—while also warning that possessing cannabis, even for medical use, carries “serious consequences.” As President Donald Trump considers a cannabis rescheduling proposal—and after he posted a video on the health benefits of CBD—the Department of Homeland Security (DHS) and Customs and Border Protection (CBP) are sending a conflicting message about cannabis. In a press release about an August “surge” in drug seizures that was sent out on Tuesday, DHS said that CBP, as part of its “mission to stop harmful drugs from entering the United States,” was announcing that “seizures of deadly drugs—including fentanyl, cocaine, heroin, methamphetamine, and marijuana—increased substantially from July to August.” That rhetoric as it concerns marijuana departs from how most people view and compare the plant with the other listed substances that can be associated with overdose deaths. By the federal government’s own admission in the past, cannabis has not on its own caused a fatal overdose. “Cartels are increasingly desperate to keep doing business, but the Trump Administration is stopping their deadly operations,” CBP said. While looping together marijuana and drugs like fentanyl might raise eyebrows, cartel-related crime associated with cannabis has been a consistent talking point in Congress. In fact, it was the subject of a House Homeland Security Subcommittee on Oversight, Investigations, & Accountability hearing last month that focused on a so-called “invasion” of Chinese and Mexican cartels via illicit cannabis operations. “Secretary Noem and the Department of Homeland Security are fulfilling President Trump’s promise to make America safe again by dismantling drug cartels and stopping the flow of deadly drugs into American communities,” DHS Assistant Secretary Tricia McLaughlin said. “Thanks to President Trump, fewer American families will be torn apart by addiction, fewer lives will be lost to overdoses, and fewer profits will go to violent cartels.” Separately, CBP posted a reminder on social media on Tuesday that cautioned travelers against bringing cannabis across the border. “Attention, travelers! Did you know that marijuana is still a controlled substance under U.S. federal law?” it said. “This means that selling, possessing, producing, or distributing both medical and recreational cannabis is illegal!” Attention, travelers! Did you know that marijuana is still a controlled substance under U.S. federal law? This means that selling, possessing, producing, or distributing both medical and recreational cannabis is illegal! Think twice before crossing the border with marijuana.… pic.twitter.com/i0ufyMyulV — CBP (@CBP) September 30, 2025 “Think twice before crossing the border with marijuana. Doing so could lead to serious consequences like seizure, hefty fines, or even arrest!” it said. “Plus, it might affect your ability to enter the U.S. Stay informed and safe and #KnowBeforeYouGo.” The messages from DHS and CBP aren’t entirely surprising, as the agencies have maintained a staunch criminalization mentality when it comes to cannabis even amid reconsideration of the federal scheduling of marijuana and other comments from the president suggesting that there are outsized penalties for possession and use of the plant. Back in January, for example, DHS and CBP urged a federal court to dismiss a lawsuit from licensed New Mexico marijuana businesses who claimed the agencies have been unconstitutionally seizing state-regulated marijuana products and detaining industry workers at interior checkpoints. CBP’s actions against state-legal marijuana business has also received pushback from other members in Congress as well. In 2023, the agency also published an overview of issues related to the non-intoxicating cannabinoid CBD, warning that such products remain unregulated and may contain concentrations of THC that could show up in a drug test for employees. However, CBP did update its workplace policy last year, narrowing the window of employment ineligibility over past marijuana use from two years to three months. A GOP senator subsequently called on the agency to reverse that decision. Photo courtesy of Philip Steffan. The post Feds Call Marijuana A ‘Deadly’ Drug And Say Even Medical Cannabis Has ‘Serious Consequences’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Three months into a major marijuana tax hike in California, a new law putting a pause on the increase has officially taken effect. Gov. Gavin Newsom (D) signed the tax relief legislation from Assemblymember Matt Haney (D) late last month. Now, as of Wednesday, consumers will not be paying the increased excise tax—at least until October 2028. “We’re rolling back this cannabis tax hike so the legal market can continue to grow, consumers can access safe products, and our local communities see the benefits,” Newsom said at the time of the bill signing. Haney said that “California’s cannabis economy can bring enormous benefits to our state, but only if our legal industry is given a fair chance to compete against the untaxed and unregulated illegal market.” “AB 564 helps level the playing field,” he said. “It protects California jobs, keeps small businesses open, and ensures that our legal cannabis market can grow and thrive the way voters intended.” State officials announced in June that the cannabis excise tax rate would increase from 15 percent to 19 percent on July 1, prompting concern from industry stakeholders and consumer advocates. Newsom previously supported including a tax freeze in a budget trailer bill, but that didn’t come to fruition. Assembly Speaker Robert Rivas (D) also backed the delay, but Senate President Pro Tempore Mike McGuire (D) reportedly blocked it from the budget legislation. Before being amended in committee, the newly enacted legislation’s pause of the cannabis tax increase would have been in effect until June 30, 2030. After that, on a biennial basis, regulators would adjust the tax rate “by a percentage that will generate an amount of revenue that would have been collected pursuant to the cultivation tax imposed prior to its discontinuation, as specified, not to exceed 19 percent,” according to a summary. The Senate Appropriations Committee, however, moved to shorten the period that the reduction will be in effect, to October 2028. The new law will make it so the California Department of Tax and Fee Administration (CDTFA), working with the Department of Finance, will be required to “adjust the cannabis excise tax rate upon purchasers of cannabis or cannabis products” based on the “additional percentage of the gross receipts of any retail sale by a cannabis retailer that the department estimates will generate an amount of revenue equivalent to the amount that would have been collected in the previous fiscal year,” the text says. The department will need to “estimate the amount of revenue that would have been collected in the previous fiscal year pursuant to the weight-based cultivation tax” and “estimate this amount by projecting the revenue from weight-based cultivation taxes that would have been collected in the previous calendar year based on information available to the department.” “The specific goal of the cannabis excise tax rate reduction is to provide immediate tax relief to the cannabis industry,” the measure states. “The efficacy of this goal may be measured by the Legislature by the amount of gain or loss in cannabis excise tax revenues resulting from the cannabis excise tax rate reduction allowed by this act.” It also mandates that CDTFA, on or before December 1, 2026 and each subsequent year the California “submit a report to the Legislature…detailing the amount of gain or loss in cannabis excise tax revenues resulting from the cannabis excise tax rate reduction allowed by this act.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, a leading veterans group is calling on the governor to sign a bill that would streamline research on marijuana and psychedelics. The legislation from Assemblymember Christopher Ward (D) would empower the Research Advisory Panel of California (RAPC) to expedite reviews of research proposals for cannabis on marijuana and psychedelics, through January 2028. California officials are also inviting research proposals for a second round of grants under a program meant to better educate the public on the state’s marijuana law and help policymakers make informed decisions on the issue. In June, the Governor’s Office of Business and Economic Development (GO-Biz) announced the recipients of over $52 million in community reinvestment grants to nonprofits and local health departments, also funded by marijuana tax revenue. That marked the seventh round of cannabis-funded California Community Reinvestment Grants (CalCRG) under the state program. Legalization in California has created a number of new grant programs aimed at addressing the consequences of marijuana prohibition and attempting to nurture a strong, well-regulated legal industry. California’s Supreme Court separately delivered a victory for the state’s marijuana program in June, rescinding a lower court ruling in a case that suggested federal prohibition could be used locally to undermine the cannabis market. The state Supreme Court ruling also came just weeks after California officials unveiled a report on the current status and future of the state’s marijuana market—with independent analysts hired by regulators concluding that the federal prohibition on cannabis that prevents interstate commerce is meaningfully bolstering the illicit market. The governor did sign a bill in 2022 that would have empowered him to enter into interstate cannabis commerce agreements with other legal states, but that power was incumbent upon federal guidance or an assessment from the state attorney general that sanctioned such activity. Meanwhile, a California Senate committee recently declined to advance a bipartisan bill that would have created a psilocybin pilot program for military veterans and former first responders. The post California Marijuana Tax Cut Officially Takes Effect, With Planned Increase Delayed Through At Least 2028 appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Superior Place, My organization is a great believer during ad opinions regarding online websites that will let the webpage novelists recognize that they’ve put in an item worthwhile that will the online market place! 1xbet promo code today Brilliant text. A posting is affecting loads of imperative complications one's world. Most people can't be uninvolved so that you can all these complications. The following posting supplies plans plus basics. Pretty enlightening plus simple. meilleur code promo linebet Wonderful article, their quite a neat web site that you've below, carry on the excellent operate, are going to be rear. new casino no deposit bonus

“Our industry is not their piggy bank. Our wallets are not their budget overruns.” By Ben Solis, Michigan Advance The proposed new wholesale tax on marijuana products to fund road repairs in the next state budget and years down the road is much too high and would result in job losses for a booming Michigan cannabis industry, advocates and lawmakers said Tuesday as they rallied for a lower tax rate. At least two Democratic lawmakers who attended the rally—state Reps. Donavan McKinney of Detroit and Mike McFall of Hazel Park—also signaled that they were working behind the scenes to get that rate much lower before a final vote is taken. At present, both McFall and McKinney said they would vote no on the final budget if the rate remained. Michigan lawmakers reached a loose framework to fund the government last week, but it included a new 24 percent wholesale tax on products sold at dispensaries across the state. That sent the cannabis industry and their allies into a frenzy as they warned that such a tax would hamstring the industry’s growth and result in fewer jobs. On Tuesday afternoon, lawmakers were still in the throes of hammering out a final budget plan, with no clear end in sight despite signals that the government would stay open and not shut down on Wednesday when the new fiscal year begins (though by the end of the day lawmakers passed a temporary budget extension through October 8). Still, the money for the Legislature’s road funding plan had to come from somewhere, whether that was from schools—which advocates rallied against Tuesday—or from the new proposed tax on pot for potholes. Those working for or on behalf of the cannabis industry gathered for a rally on the Capitol steps in Lansing to send lawmakers and Gov. Gretchen Whitmer (D), who had earlier in the year proposed a more than 30 percent tax, a clear message: Keep off their grass. “Our industry is not their piggy bank. Our wallets are not their budget overruns,” said Mike DiLaura, CCO and general counsel for House of Dank, one of many cannabis companies operating in Michigan. “It is our time, not just as an industry, but as citizens of this great state, to put our feet down and say, ‘enough is enough.’” DiLaura continued by saying that the industry has, since recreational cannabis was legalized in 2020, raised nearly $2 billion in taxes for Michigan over the last five years. “But they say it’s not enough,” DiLaura said. “When will it ever be enough?” Several other advocates and industry leaders spoke at the rally, all mentioning that even if they lost the battle to either stop the tax hike or reduce it, they would continue the fight in court or seek a full repeal of the law down the pike. The rally also featured two allies in McKinney and McFall. Both said they voted against the proposal in House Bill 4951 when it passed the House last week, noting that their communities have greatly benefited from recreational cannabis shops and associated businesses like grow operations. “Hazel Park was all in on marijuana from the very beginning. As some of you might know, we even gave Tommy Chong the key to the city at one point,” McFall said. “But what a lot of people don’t realize is how this is going to impact local municipalities. They’re talking about cutting revenue sharing, which is the money that goes back from the state. This is also going to impact that.” McFall said Hazel Park got half a million in tax dollars last year, and that money helped pay for emergency services and other amenities. McKinney said that the Eight Mile corridor is filled with marijuana shops that have transformed vacant, abandoned buildings while also delivering what he called the best marijuana in the nation. “I think Snoop Dogg said something like that,” McKinney quipped. But in all seriousness, he said that the proposal was “BS,” and the new tax rate was too high. McKinney added that he and McFall were just two of a few legislators who were willing to stand firm against the proposal, and that there was work going on behind closed doors to lower the rate if it was absolutely necessary to fund roads. “We don’t know what that number will be, but we for sure know it’s not going to be 24 percent,” McKinney said. This story was first published by Michigan Advance, and additional clarification was added by Marijuana Moment. The post Michigan Marijuana Industry Rallies Against Tax Hike Proposal That’s Advancing In The Legislature appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

That can feel great to learn these kinds of useful and also special posts on your own sites. 1xbet promo code pakistan This is often as a result exquisite and even very creative. Freezing take pleasure in that tones and even whomever makes the application with the -mail can be beaming. code promo linebet maroc her in fact awesome blog page. her realy content rich and then a this fantastic profession. i prefer this unique. casino bonus no deposit

this really is great and also meanful. this really is great website. Relating is quite beneficial factor. you might have actually aided a lot of people which check out website and offer these usefull details. 1xbet promo code free bet I’m stirred along with the surpassing and additionally preachy list of you ought to produce such smaller timing. code promo linebet algerie Thanks for the post and great tips.. even I also think that hard work is the most important area of getting success. 200 sign up bonus casino

Positive site, where did u come up with the information on this posting? I'm pleased I discovered it though, ill be checking back soon to find out what additional posts you include. bandar togel Thank you for helping people get the information they need. Great stuff as usual. Keep up the great work!!! koi toto I think this is an informative post and it is very beneficial and knowledgeable. Therefore, I would like to thank you for the endeavors that you have made in writing this article. All the content is absolutely well-researched. Thanks... bandar togel

“The integrity of a lawful election is being stolen by self-righteous politicians who beat their chests, trumpeting election integrity while quietly using you as a commission to undermine it.” By Zach Wendling, Nebraska Examiner Supporters have questioned for months whether the voter-authorized Nebraska Medical Cannabis Commission would meet its October 1 deadline to grant its first licenses. The answer is no: The commission will miss that deadline by at least one week, in the wake of two resignations sought and received by Gov. Jim Pillen (R) of liquor regulators who jointly served on the medical cannabis board. The Medical Cannabis Commission confirmed the new timeline Tuesday at a meeting originally meant to approve the first cultivator licenses and move toward the first steps of a medical cannabis supply chain in the state. However, two of the five cannabis commissioners resigned Monday, both of whom served on a three-member team evaluating and scoring cultivator applications received by September 23. Now, the remaining commissioners will independently review applications by next Tuesday, when commissioners will meet to decide whether to award up to four cultivator licenses. “We would just ask for your understanding that this is a situation that none of us created in this, where we’re at right here,” Commissioner Lorelle Mueting of Gretna said Tuesday. “We would just hope you understand that we’re working through this the best that we can to make sure that we get the licenses issued in a timely manner and evaluated and issued in time.” Resignations impacted timeline Dr. Monica Oldenburg, an anesthesiologist who chairs the commission, had been on the initial evaluation team with former Commissioners Bruce Bailey of Lincoln and Kim Lowe of Kearney. The plan was to average out scores before this week’s meeting and then vote on whether to grant the first licenses. Oldenburg, a May appointee of Pillen’s, has a narrower view of what the voters passed than Bailey and Lowe, such as on smoking. Bailey had the most permissive view of voters’ wishes. Under a state law passed by about 67 percent of voters last November, with majority support in 46 of 49 legislative districts, the commission needed to, “No later than October 1, 2025, begin granting registrations to applicants that meet eligibility standards and other requirements established by the commission.” The guidelines were established by an early July 1 deadline set by voters. Bailey and Lowe resigned Monday, tossing a major wrench into whether the commission would meet its Wednesday licensing deadline. Pillen’s request followed the unsealing last week of federal corruption charges against former Liquor Control Commission Executive Director Hobert “Hobie” Rupe. Rupe has pleaded not guilty. The indictment did not implicate any member of the Liquor Control Commission. While Pillen has rejected all of the pending Liquor Control Commission regulatory changes proposed under the former director, his staff has confirmed that he has no plans to shelve medical cannabis regulations. Bailey had chaired the Liquor Control Commission and served since 2014. Lowe had served on that commission since 2021. Retired Judge J. Michael Coffey joined the commission in June, a vacancy created after Pillen had previously requested the resignation of a third commissioner, Harry Hoch Jr., in May. Oldenburg, Mueting and Coffey will review applications on metrics that have not been publicly released. Passing applicants need to average at least 70 out of 100. Applications were entered into a “lottery” to randomly order submissions. Pillen opposes the legalization of recreational marijuana and has said Coffey, Mueting and Oldenburg—all his appointees—will keep Nebraska’s medical cannabis system carefully regulated. He will appoint two commissioners to succeed Bailey and Lowe. Licensing lawsuit likely The commission also faces a potential legal threat from Nebraska Attorney General Mike Hilgers (R). His office has threatened to sue the commission once the first licenses are issued. “This office has long held that any attempt to license entities to dispense marijuana in Nebraska violates the federal ban [on marijuana],” then-acting Deputy Solicitor General Zach Pohlman testified at a March legislative hearing. “If the Medical Cannabis Commission tries to do so, the Attorney General’s Office will challenge that action as preempted and unenforceable.” The office has repeated the stance multiple times, including in a separate citizen-led lawsuit seeking to overturn the voter-passed laws, in which Hilgers and Pohlman say it should be the AG’s Office, not a citizen, to challenge the laws’ constitutionality. A spokesperson for Hilgers declined to confirm last week whether this remained the position of the Attorney General’s Office. A Pillen spokesperson, when asked last week whether the governor supported Hilgers’s efforts, directed questions to the AG’s Office. A separate voter-passed law authorizes anyone with a health care practitioner’s recommendation to possess up to 5 ounces of medical cannabis in Nebraska. It passed with 71 percent voter support last November, including majority support in every legislative district. Nebraska became the 39th state to authorize a medical cannabis program. ‘We can get started today’ Troy Burgess, one of the cultivator applicants, said Tuesday that once a cultivator begins growing marijuana, it could be five months before anything is sent to a product manufacturer (another license type) and another 4-6 weeks before it is ready for sale at a dispensary (another license type). “These patients need relief. We need to get it to them,” Burgess told the commission. “We can get started today.” The proposed regulations the commission is considering would cap the four licensed cultivators to no more than 1,250 flowering plants each at any one time. With two expected harvests in the year, that’s up to 10,000 harvestable plants, if all plants are grown successfully and are contaminant-free. The commission is anticipating an initial program to support about 20,000 patients. All products would need to meet strict testing requirements as set by the commission. A public hearing on the proposed regulations is set for 1 p.m. on October 15 at the Nebraska State Office Building. The hearing could last up to three hours, with testifiers limited to two or three minutes apiece. Written comments can be submitted up to 11:59 p.m. on October 15 by mail to the Nebraska Medical Commission, PO Box 95046, Lincoln, NE 68509-5046; by fax at 402-471-2814 or by email to mcc.contact@nebraska.gov. ‘Integrity’ Dominic Gillen of Bellevue, who has worked with advocates of medical cannabis for more than a decade in Nebraska, spoke to the commission Tuesday about “integrity” and said the full weight of voter trust is on commissioners, not politicians behind the curtain “pulling the strings.” “The integrity of a lawful election is being stolen by self-righteous politicians who beat their chests, trumpeting election integrity while quietly using you as a commission to undermine it,” Gillen said. Many Nebraskans again urged the commission to approve of smoking, vaping and raw flower sales, which its proposed regulations reject. Angelica Marsaglia told commissioners they needed to implement the law, not rewrite it. “That exceeds your authority, undermines the will of the voters and is unlawful,” Marsaglia said. Gillen said Bailey was guilty of “honoring his commitment to the voters” and “should be hailed as a hero” for standing up for voters, such as pushing for more cultivators and a higher plant cap. “The politicians have made their heartless choice,” Gillen said. “You, on the other hand, still have one.” The Medical Cannabis Commission will meet next at 2 p.m. October 7 in Lincoln. What would the latest medical cannabis regulations mean? If finalized, the state’s medical cannabis regulations would license up to four cultivators, four product manufacturers, 12 dispensaries and 12 transporters. The guidelines would also establish a “Recommending Health Care Practitioner Directory” and also make Nebraska’s program essentially a low-THC variety. Under the regulations, patients or caregivers could purchase up to 5 ounces of medical cannabis in a 30-day period, which is about 142 grams. Of that, patients could purchase no more than 5 grams of delta-9 tetrahydrocannabinol (THC) from the same dispensary within 90 days. Delta-9 THC is the part of cannabis most associated with a “high.” The regulations would allow no more than 12 medical cannabis dispensaries statewide, arranged by judicial district. That could mean one dispensary in Douglas County (584,526 residents), Lancaster County (322,608 residents), Sarpy/Cass Counties (217,202 residents) and Buffalo/Hall Counties (112,979 residents), according to 2020 census data. Dispensaries would not be able to sell smoking or vaping products or edibles of any kind. Oral tablets with a “thin layer” of flavoring to make the products easier to swallow could be sold. Under current law, a patient or qualified caregiver with a recommendation from any health care practitioner can legally possess up to 5 ounces of medical cannabis, in any form. But no licenses have yet been issued, so cannabis can’t legally be purchased in Nebraska yet. The latest set of emergency regulations ends December 7. Commissioners say that set of regulations can be extended for one additional 90-day period. Once the Medical Cannabis Commission approves a more permanent set of regulations, commissioners will send the regulations to Attorney General Mike Hilgers (R) for legal review and Gov. Jim Pillen (R) for final approval. This story was first published by Nebraska Examiner. Photo courtesy of Brian Shamblen. The post Nebraska Officials Miss Medical Marijuana Licensing Deadline As Regulators Resign appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Cheers pertaining to delivering the latest changes in connection with worry, My spouse and i expect go through additional. 1xbet promo code free bet Wonderful article, their quite a neat web site that you've below, carry on the excellent operate, are going to be rear. code promo linebet maroc This can be a excellent post, Many thanks with regard to providing me personally these details. Maintain publishing. live casino bonus

Cheap content, With thanks just for stating This approach skills. Wonderfully developed page, only if all of the the blogosphere obtainable the equivalent degree content and articles simply because, websites became a more desirable space. Delight continue! 1xbet promo code free bet Genuinely reliable, wonderful, fact-filled data below. Your current blogposts Do not ever let down, knowning that surely holds true below also. Anyone often create a unique go through. Could you explain to I am just satisfied?: )#) Carry on the fantastic content. code promo linebet casino I simply reckoned it is an outline to share in case other companies was first experiencing difficulty looking for still Now i'm a small amount of doubting generally if i here's permitted to use artists and additionally explains relating to right. 100 free bonus casino no deposit philippines

Massachusetts lawmakers have approved a bill to establish a pilot program for the regulated therapeutic use of psychedelics. And two committees have separately held hearings to discuss additional psilocybin-related measures. Less than two weeks after advancing out of the legislature’s Joint Committee on Mental Health, Substance Use and Recovery Hearing, the pilot program legislation from Sen. Cindy Friedman (D) moved through the Joint Committee on Health Care Financing on Tuesday with a “do pass” recommendation. The bill, S.1400, is light on specifics, leaving many details of the pilot program up to regulators with the Department of Public Health (DPH). But in general, it calls for a “pilot program to allow for the monitored mental health care of clinically appropriate patients using psychedelic materials.” It would involve the “on-site administration by a multi-disciplinary care team in a supervised licensed mental health clinic setting.” DPH could only issue licenses for up to three health facilities to administer and study the psychedelics in the state. They would be tasked with “establishing the best and safest clinical practices for psychedelic mental health treatment programs in the commonwealth and for the purposes of collecting patient outcomes data regarding the benefits of psychedelic pharmacotherapy.” “Eligible pilot program organizations must exclusively focus operations and treatment on mental health and cannot be subsidiaries, affiliates or members of cannabis industry organizations, psychedelic molecule development companies or pharmaceutical companies,” the bill text states. The department would be required to develop rules for the program, including setting standards for people to apply to participate, patient assessments and ongoing monitoring, clinical staffing and the administration of psychedelic medicines. “All pilot program participant organizations must track patient care outcomes data related to the identification, diagnosis and psychedelic treatment of depression, anxiety, post-traumatic stress disorder and substance use disorder,” it says. “These data sets must be shared with the department to assist in the refinement of best clinical protocols and final regulatory frameworks for the safe use of psychedelic material in Massachusetts.” Jamie Morey, executive director and co-founder of the advocacy group Mass Healing said the bill’s advancement “brings the promise of healing one step closer for Massachusetts residents suffering from trauma, depression, and other treatment-resistant conditions.” “We thank Senator Friedman and the committee for seeing the desperate need for new treatment options to help reduce deaths of despair and taking bold action to put Massachusetts at the forefront of a mental health revolution that will save countless lives,” she said. The bill, as well as a separate measure to provide a more limited pilot program for psilocybin therapy alone, will also be the focus of a hearing on November 10 before the Joint Committee on Mental Health, Substance Use and Recovery. At separate hearings on Monday, lawmakers considered a psilocybin pilot program proposal from Rep. Lindsay Sabadosa (D), as well as a broader measure to legalize and regulate psilocybin for adults that’s being sponsored by Rep. Patrick Kearney (D). Members of the Joint Committee on Revenue took up the legalization measure, while the Joint Committee on Public Health discussed the psilocybin pilot program proposal. Members in both panels took testimony from experts about the therapeutic potential of the psychedelic and ramifications of criminalization, but did not act on the bills. Graham Moore, educational director for Mass Healing, told the revenue panel that “blanket prohibition can actually cause more harm than good.” “The largest preventable cause of death in this state is tobacco, and psilocybin has been shown to help people break that addiction among many other improvements to behavioral health,” he said. Joe McKay of Clusterbusters told lawmakers about how using psilocybin has helped to manage cluster headache condition he began experiencing after 9/11, when he was one of many firefighters who responded to the World Trade Center attack in New York City. “I would take a low dose a few times a year to keep the attacks away. And during one experience, I had this 10,000-foot view of my life and I realized how I had changed since 9/11 and that I was living with PTSD. I also realized that I was taking the painkillers to numb the emotional pain and not the physical,” he said. “I sought out help from an underground therapist, and today I no longer drink alcohol and I have not taken a painkiller since,” McKay said. “And I can honestly say that psilocybin healed me, both physically and mentally.” While multiple cities across Massachusetts have enacted local psychedelics decriminalization initiatives, voters rejected a statewide ballot measure last year that would have legalized substances such as psilocybin, ibogaine and DMT for adults. Ahead of that vote, the governor signed a military veterans-focused bill that includes provisions to create a psychedelics working group to study and make recommendations about the potential therapeutic benefits of substances like psilocybin and MDMA. Meanwhile, the legislature’s Joint Committee on the Judiciary in July held a hearing on four of 12 psychedelics-related bills that were filed for this session, with the Massachusetts Psychiatric Society (MPS) endorsing one that would decriminalize certain entheogenic substances. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Separately in Massachusetts, the state attorney general recently certified and prepared summaries for dozens of proposed 2026 ballot initiatives—including a pair that would roll back adult-use marijuana legalization in the state. Regulators are also working to finalize rules to allow for a new cannabis consumption lounge license type, which they hope to complete soon. The legislature’s Joint Committee on Cannabis Policy last month approved bills to provide employment protections for marijuana consumers and expand the state’s medical cannabis program, in part by adding post-traumatic stress disorder (PTSD) and opioid use disorder to the list of qualifying conditions. State lawmakers have also been considering setting tighter restrictions on intoxicating hemp-derived products and a plan to allow individual entities to control a larger number of cannabis establishments. Photo elements courtesy of carlosemmaskype and Apollo. The post Massachusetts Lawmakers Advance Psychedelics Pilot Program Bill As Committees Weigh Additional Psilocybin Measures appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I got lost in a small mountain town during a hiking trip and ended up meeting some quirky locals who completely changed my plans. Sharing this feels unpredictable, almost like trying to survive Level Devil where every twist tests your patience.

Wow, cool post. I’d like to write like this too – taking time and real hard work to make a great article… but I put things off too much and never seem to get started. Thanks though. link bolahit Thanks for your insight for your fantastic posting. I’m glad I have taken the time to see this. bandar slot This is the type of information I’ve long been trying to find. Thank you for writing this information. 오피스타 Fantastic blog! Do you have any tips and hints for aspiring writers? I’m planning to start my own website soon but I’m a little lost on everything. Would you propose starting with a free platform like WordPress or go for a paid option? There are so many options out there that I’m completely overwhelmed .. Any suggestions? Many thanks! toto togel Cool stuff you have got and you keep update all of us. iosbet daftar

Very useful info. Hope to see more posts soon!. situs bolahit Thank you for very usefull information.. bandar slot gacor This is a brilliant blog! I'm very happy with the comments!.. 오피스타 I recently came across your blog and have been reading along. I thought I would leave my first comment. I don’t know what to say except that I have enjoyed reading. koi toto Awesome article! I want people to know just how good this information is in your article. It’s interesting, compelling content. Your views are much like my own concerning this subject. iosbet login

WI GOP medical marijuana bill; German gov’t legalization report; Alcohol industry group welcomes THC hemp drink maker; Roger Stone on Trump & cannabis Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The Food and Drug Administration has added “Cannabinoid Hemp Products (such as products containing CBD)” as a selectable option on adverse event reporting forms in order to better track the health impacts of increasingly popular hemp-derived consumables. Wisconsin’s Republican Senate president joined other GOP lawmakers in filing legislation to legalize medical cannabis—saying that “someone who suffers from a serious health condition should not have to make the choice to travel to another state or break the law.” A new report from the German Ministry of Health shows that the country’s marijuana legalization law has not led to an increase in youth use or cannabis-related traffic accidents—though its limited rollout has not yet significantly displaced the illicit market. Republican political operative Roger Stone said President Donald Trump can outdo Democrats by rescheduling marijuana—claiming that members of the other party “always talk about” cannabis but “did nothing” when they controlled the White House and Congress. “I pray that President Trump will make a very different decision.” Wine & Spirits Wholesalers of America added a company that makes THC-infused drinks to its membership roster for the first time, with CannaBuzz joining as an associate member. The Michigan Cannabis Industry Association is considering filing a lawsuit to challenge a marijuana tax increase that’s advancing in the legislature, saying it failed to reach a three-fourths majority vote threshold needed to amend voter-approved initiatives. / FEDERAL The White House Office of National Drug Control Policy is moving to recompete awards for the Drug-Free Communities grants program. The U.S. Court of Appeals for the Tenth Circuit is allowing a prosecution to proceed against an Oklahoma lawyer who allegedly helped clients circumvent residency requirements for medical cannabis businesses. The Congressional Research Service noted a recent U.S. Court of Appeals for the Tenth Circuit ruling on marijuana consumers’ gun rights. / STATES The Nebraska attorney general’s office sent cease and desist letters to every retailer in the state that is allegedly illegally selling synthetic THC-containing products. A U.S. Virgin Islands judge ruled that police may not use the smell of marijuana alone as probable cause for vehicle searches. Vermont regulators posted guidance on cannabis testing lab action limits. Iowa regulators published guidance on consumable hemp products. California regulators posted a report on cannabis business tax deductions. Michigan regulators announced a consent order and stipulation with a marijuana business that will result in it surrendering its license as a result of alleged violations. The North Carolina Advisory Council on Cannabis met. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL Burlington, Vermont officials are looking for a location to house a state-funded safe consumption site for illegal drugs. / INTERNATIONAL Uruguayan officials are moving to include CBD in the national therapeutic formulary. South Africa’s Agricultural Research Council is preparing to build a cannabis research facility. / SCIENCE & HEALTH A study suggested that a “CBD–mupirocin formulation holds considerable promise for clinical application in the management of skin infections caused by resistant S. aureus strains.” A study found that “cannabidiol prevents cognitive and social deficits in a male rat model of Alzheimer’s disease through CB1 activation and inflammation modulation.” / ADVOCACY, OPINION & ANALYSIS MSNBC host Lawrence O’Donnell suggested that President Donald Trump may have been high on marijuana when he posted a “goofy” video about the medical benefits of cannabis. / BUSINESS Curaleaf, Inc. is being sued by a former employee over alleged “systemic diversion” of cannabis products. Simplifya raised $2 million in new equity capital. Ascend Wellness Holdings, Inc. entered into and closed a $9.3 million secured financing transaction pursuant to which it mortgaged real estate on three properties in Ohio. Flowhub launched a new marketing suite product for dispensaries. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post FDA adds cannabis products to adverse event reporting form (Newsletter: October 1, 2025) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

What an inspiring experience at the Midwest Canna Conference! It's amazing to see Missouri women pioneering in this emerging industry. Alexis Simmons' innovative approach to reimagining the traditional grinder sounds fascinating - innovation reminds me of how creative developers transform simple concepts in Geometry Dash into incredible experiences. Thanks to the admin for sharing these industry insights!

Superbly written article, if only all bloggers offered the same content as you, the internet would be a far better place.. trading in mobile

One of President Donald Trump’s longtime advisors, Roger Stone, says his administration has an opportunity to move forward with marijuana rescheduling—or, even broader legalization—in a way that Democrats who regularly tout the reform failed to achieve when they controlled the White House and Congress. During a segment of “The Stone Zone” on 77WABC Radio that aired on Monday, Stone responded to Trump’s social media post over the weekend where he shared a video that touted the health benefits of hemp-derived CBD, particular for seniors. “The video posted by President Trump talked about the use of CBD oil to alleviate pain, lower stress and result in better sleep. CBD is the non-psychoactive compound found in cannabis,” Stone said. “It does not get you high, and it is a source of most of the medicinal benefits from the cannabis plant.” He added that it’s well-understood that the president has been a “supporter of states’ rights on the question of the legalization of cannabis for medicinal purposes.” “That has always been his position. Go all the way back to the 2016 campaign,” he said. “I myself have been a major advocate for President Trump reclassifying or declassifying cannabis. Right now, cannabis is considered a Schedule I drug, along with heroin, MDMA and LSD.” While Trump didn’t directly comment on the content of the video he shared over the weekend, he has previously endorsed moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). And he said last month that a decision on that reform would be made within weeks. Stone somewhat misstated the impact of that potential policy change, saying it would “make it allowable for medicinal use” and “also solve a number of the banking issues” for state-licensed cannabis businesses. Will President Trump Reclassify or Declassify Marijuana to Expand Its Legal Medicinal Use? The StoneZONE — Tonight, only on 77WABC Radio! Listen LIVE at 8 PM ET: https://t.co/53a3PGhes4 pic.twitter.com/azS86U7Lje — Roger Stone (@RogerJStoneJr) September 29, 2025 Moving marijuana to Schedule III would remove certain research barriers, but it would need to be approved by the Food and Drug Administration (FDA) to be accessible as a prescribed medicine, which is unlikely in botanical form. And it would let cannabis businesses take federal tax deductions they’ve been barred from under an Internal Revenue Service (IRS) code known as 280E, but since marijuana wouldn’t be federally legalized, banking issues for the industry would likely persist. “This particular move by the president is particularly unpopular with Big Pharma. You see, they would much prefer to sell you pharmaceutical drugs to do far greater damage,” Stone said. “It’s really only a matter of common sense. Alcohol is probably far more damaging to the human system than cannabis, even in the full sense of marijuana, could ever be—yet alcohol sales are legal, they’re regulated and they’re taxed by the states. So why not cannabis [which is] far less damaging than oxycontin for pain?” Stone—a Republican political operative who has served as a senior campaign aide to Trump as well as to Presidents Richard Nixon and Ronald Reagan during their administrations—noted that he became a “convert” for legalization when his father was dying from cancer and cannabis “alleviated his suffering when his time came.” He’s reiterated the impact of that experience in multiple interviews over the years. “I have no qualms about my sister and I deciding to get him the cannabis that eased the final days of his life,” he said. “I hope President Trump does either reclassify, or even better, declassify cannabis—and does it now.” He also pointed out that, while “Democrats always talk about” marijuana reform, they declined to enact meaningful policy changes during prior sessions when they wielded control of both chambers of Congress and the presidency. He said that was the case under former President Barack Obama, but it was also the case under former President Joe Biden for one session—though Biden did initiate the rescheduling process that is now being considered by Trump. “They did nothing,” Stone said. “I pray that President Trump will make a very different decision.” The GOP operative also made the case for cannabis reform in an op-ed for Marijuana Moment earlier this month. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, the Republican Senate sponsor of a bipartisan cannabis banking bill said recently that Trump rescheduling marijuana would be an “important domino” to advance his legislation. Whether Trump ultimately decides to move forward with rescheduling remains to be seen. Despite his endorsement of the policy change on the campaign trail ahead of his election for a second term, he declined to restate that support when asked about it during a briefing late last month—though he did say a decision would come within weeks. Image element courtesy of Gage Skidmore. The post Trump Can Outdo Democrats By Rescheduling Marijuana When They Failed To Do So, Roger Stone Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

German officials have released a report on the impact of the nation’s marijuana legalization law, finding that fears from opponents about youth use, traffic safety and more have so far proved largely unfounded. However, the illicit market has not meaningfully diminished under the limited legal regulatory model that has been rolled out in the country to date. The interim report, which was required under the cannabis law enacted last year, assessed a series of health, public safety and economic factors associated with the end of prohibition. Among the most notable findings in the document published on Monday is the fact that youth marijuana use has continued to decline, even after possession and home cultivation were legalized for adults and social clubs offering access to members opened. Further, “no clear changes in the previous trend in cannabis consumption among adults could be observed,” the report, conducted on behalf of the federal Ministry of Health, says, according to a translation. “The percentage increase in adults who have consumed cannabis in the last 12 months, which has been observed since approximately 2011, is likely to continue…without any drastic changes,” it says. A separate recent study conducted by German federal health officials also found that rates of marijuana use declined among youth after the country legalized adult-use cannabis, contradicting one of the more common prohibitionist arguments against the reform. Another finding of the new legalization evaluation concerns traffic safety, with researchers determining that there’s been no meaningful change in incidents on the roadways associated with the policy change. “In the area of ​​road safety, partial legalization has so far shown no significant changes in self-reported driving under the influence of cannabis or in the number of people killed or injured in road traffic,” the report states. Early data on the impact of legalization on the illicit market indicates that the law has “not yet made a significant contribution to the displacement of the black market intended by the legislature,” the report found. One reason for the continued presence of the illegal market could be related to how Germany’s legalization law is being rolled out, with a limited number of social clubs that grow cannabis for members to consume—but without a comprehensive commercial industry that could provide wider access to adults. And even if broad retail launches, it may take time to substantially transition consumers to the legal market, which has been the case in Canada and U.S. states that have enacted the reform. For now, if Germany intends to substantially shift people to the legal market, “the framework for the approval and operation of cultivation associations must be simplified,” the report says. It also advises that, based on current information, there’s not a need to change the possession limit of 25 grams. “The first interim report published today confirms that the legalization of cannabis was the right and long overdue step,” MP Carmen Wegge of the Social Democratic Party (SPD) said. “The independent evaluation shows no significant increase in cannabis consumption among adults and even a decrease among minors, no noticeable negative effects on the health of adults, and significantly fewer criminal proceedings,” she said. “But the core message is clear: Partial legalization protects health and improves the ability of the constitutional state to act.” But Federal Health Minister Nina Warken, a member of the anti-legalization Christian Democratic Union, said the results so far show “worrying trends, despite the lack of further data in some areas.” “We will have to discuss possible need for action together with the coalition parties and the security authorities,” she said. Germany’s former health minister Karl Lauterbach, who spearheaded the government’s legalization plan, responded to the report, saying “cannabis consumption among young people continues to decline despite legalization.” Der Cannabiskonsum bei Jugendlichen geht trotz Legalisierung offenbar weiter zurück. Das war zu erwarten, auch andere Länder zeigen das. Wenn man den Schwarzmarkt bekämpfen will darf man Anbauclubs nicht weiter behindern. Cannabiskonsum ist kein Verbrechen https://t.co/fMPUUz2ypv — Prof. Karl Lauterbach (@Karl_Lauterbach) September 29, 2025 “That was to be expected; other countries are showing the same trend,” he said. “If one wants to combat the black market, cultivation clubs must not be further obstructed. Cannabis consumption is not a crime.” Former MP Kristine Lütke, who was one of the most vocal champions of legalization, said the report shows “there is no urgent need for action.” “Particularly encouraging: children and adolescents are not consuming cannabis more frequently than before partial legalization. The trend is rather declining,” she said. A final report on the impact of legalization in Germany is expected in April 2028. Germany’s legalization law took effect in April 2024, allowing adults to possess and grow certain amounts of cannabis and social clubs began to open, providing members with legal access to marijuana products. Following a pivotal national election earlier this year, political parties that were cooperating to form a new coalition government announced that they would be conducting an “open-ended evaluation” of the country’s marijuana legalization law—meaning that at least for now, officials will allow the policy to stay in place. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — In December, the federal minister for food and agriculture signed off on a plan to allow for research-focused commercial marijuana pilot programs to test legal and regulated access to cannabis for consumers. At the local level, the city of Frankfurt late last year announced plans to move forward with a five-year pilot program that would make cannabis products available to adults more broadly , with the city of Hanford also pursuing a similar plan. A number of other localities have also expressed interest in conducting cannabis sales pilot projects. Despite widespread concern that results of February’s election could spell doom for the legalization law, most Germans— 59 percent of eligible voters —support allowing adults to purchase cannabis from licensed stores. For the previous three years Germans were polled on the issue, support sat at just under 50 percent. But as the country’s marijuana law began being implemented last year, there was a spike in favor of the policy change. Notably, respondents who identified as CDU or CSU—two of the three coalition parties behind the new agreement—were the only political affiliations among which majorities of voters supported rolling back the reform law. German officials last year convened an international conference where leaders were invited to share their experiences with legalizing and regulating marijuana , with a focus on public health and mitigating the illicit market. Representatives from Luxembourg, Malta, the Netherlands, the Czech Republic and Switzerland were invited by German Commissioner for Addiction and Drug Issues Burkhard Blienert to the meeting in Berlin. The countries that participated in the ministerial have varying cannabis policies. Malta, for example, became the first European country to enact cannabis legalization in 2021. Luxembourg followed suit, with the reform officially taking effect in 2023 . Government officials from several countries, including the U.S., also met in Germany in 2023 to discuss international marijuana policy issues as the host nation worked to enact legalization. A group of German lawmakers, as well as Blienert, separately visited the US and toured California cannabis businesses in 2022 to inform their country’s approach to legalization. The visit came after top officials from Germany, Luxembourg, Malta and the Netherlands held their first-of-its-kind meeting to discuss plans and challenges associated with recreational marijuana legalization in 2022. The post German Government Report Shows Marijuana Legalization Hasn’t Increased Youth Use Or Traffic Accidents appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

This is the wonderful content, Cheers pertaining to supplying us this info. Preserve putting up. Buy Yamamay kuwait online

This is the wonderful content, Cheers pertaining to supplying us this info. Preserve putting up. Buy Yamamay kuwait online

A leading alcohol industry group has added a company that makes THC-infused drinks to its membership roster for the first time. Cannabuzz, a Kentucky-based manufacturer of hemp-derived THC beverages, is now an associate member of Wine & Spirits Wholesalers of America (WSWA), the company announced in a press release last week. “We’re proud to be the first THC brand to join WSWA’s THC beverage category,” Annie Rouse, Cannabuzz CEO & Founder, said in a press release. “We look forward to collaborating with the organization and providing our industry expertise to help grow a safe and accessible market.” Being a part of WSWA will give Cannabuzz “access to distributor expertise, best-practice frameworks and policy engagement as the cannabis category matures,” the company said. “Our goal isn’t just to sell drinks—it’s to help retailers, distributors, and regulators align on simple guardrails that protect consumers and give stores confidence to stock the category,” Rouse said. “We believe standardized labeling, potency appropriate serving sizes and clear age-gating will define the next chapter of adult cannabis beverages. We’re excited to join beverage-alcohol’s leading trade group to help build these responsible standards for hemp-derived THC [ready-to-drink beverages].” WSWA staff did not respond to Marijuana Moment’s request for comment for this story, though the organization’s website confirms Cannabuzz is now an associate member of the organization. The association in June called on Congress to dial back language in a House spending bill that would ban most consumable hemp products, instead proposing to maintain the legalization of naturally derived cannabinoids from the crop and only prohibit synthetic items. Members of WSWA also met with lawmakers and staffers in April to advocate for three key policy priorities that the group says is based on “sound principles of alcohol distribution.” They include banning synthetic THC, setting up a federal system for testing and labeling products and establishing state-level power to regulate retail sales. In an op-ed for Marijuana Moment in June, WSWA President and CEO Francis Creighton said echoed that point, reiterating the organization’s position that regulation is superior to prohibition. This is also consistent with WSWA’s earlier message to House and Senate Agriculture Committee last session, where the association implored congressional leaders to create a regulatory framework for hemp-based intoxicating cannabinoids—rather than impose an outright ban. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Meanwhile, bipartisan House lawmakers recently pushed back against attempts to ban hemp THC products, arguing that it would “deal a fatal blow” to the industry and, as currently included in a spending bill, violates congressional rules. To that end, the members say there are plans in the works to introduce an alternative measure to regulate the market. While the Senate ultimately stripped similar language from its version of the agriculture spending measure following a procedural protest from Sen. Rand Paul (R-KY), there’s still concern among stakeholders that it could wind up in the final package delivered to the president following bicameral negotiations. Dozens of hemp farmers from Kentucky also recently urged their state’s senior U.S. senator, Sen. Mitch McConnell (R-KY), to back off from his push to recriminalize some products that are derived from their crops. Paul, for his part, recently cautioned that the cannabis policy movement has “swung hard on the prohibitionist side” amid the ongoing debate over intoxicating hemp products. And he worries that, if things go awry, the hemp market could be decimated “within the next two weeks.” Asked about recent conversations with McConnell and Rep. Andy Harris (R-KY), Paul said “we’ve been working diligently” with the staff “trying to reach a compromise.” The post Major Alcohol Industry Trade Association Welcomes Its First THC Cannabis Beverage Member appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

This is such a great resource that you are providing and you give it away for free. I love seeing blog that understand the value of providing a quality resource for free. toto togel Positive site, where did u come up with the information on this posting? I'm pleased I discovered it though, ill be checking back soon to find out what additional posts you include. olxtoto I wish more authors of this type of content would take the time you did to research and write so well. I am very impressed with your vision and insight. togel 4d I am thankful to you for sharing this plethora of useful information. I found this resource utmost beneficial for me. Thanks a lot for hard work. bandar toto macau Nice to be visiting your blog again, it has been months for me. Well this article that i've been waited for so long. I need this article to complete my assignment in the college, and it has same topic with your article. Thanks, great share. koi toto

Wisconsin’s Senate president announced on Monday that she and two other bicameral Republican lawmakers have introduced legislation to legalize medical marijuana in the state. Senate President Mary Felzkowski (R), who’s previously sponsored a medical cannabis bill, said in a press release that she’s filed the new measure alongside Sen. Patrick Testin (R), with an Assembly companion version from Assemblymember Patrick Snyder (R). The text of the proposal hasn’t been posted yet, but Felzkowski’s prior bill would have allowed doctors to issue medical cannabis recommendations to patients with one of eight conditions, including cancer, seizure disorders, post-traumatic stress disorder and multiple sclerosis. The legislation was fairly restrictive, as it prohibited smokable marijuana products and wouldn’t have allowed patients to grow cannabis for personal use. Patients could have only obtained cannabis preparations in the form of oils, pills, tinctures or topicals. It’s not clear if the Senate president and her colleagues have expanded the scope of the reform for the new yet-to-be-released bill. “Someone who suffers from a serious health condition should not have to make the choice to travel to another state or break the law so they can try an alternative medicine for relief,” Felzkowski, a cancer survivor, said in a press release. “This legislation is about giving our friends, family members, and neighbors suffering from a chronic illness the freedom to explore another option with their doctor,” she said. “This is also a chance for small businesses in our state to take part in this market with reasonable regulations on making and selling these products, all while still protecting public safety.” As the 2025 session was set to get underway, the Senate leader said she was “hoping to have a conversation” in the legislature about legalizing medical marijuana this year—though the Republican Assembly speaker still represented “an obstacle,” she added. Meanwhile, a Republican candidate for governor of Wisconsin said in July that he was “open to considering different opportunities” when it comes to legalizing medical or adult-use marijuana in the state, though he has provided little in the way of specifics so far. On the Democratic side, current Gov. Tony Evers (D), who supports legalizing cannabis, will not be seeking re-election. But he said in June that if his party can take control of the legislature, the state can “finally” legalize marijuana so that residents don’t have to go to neighboring Illinois to visit its adult-use market. Separately in June, a poll from Marquette Law School found that two in three Wisconsin voters support legalizing marijuana. The survey found that support for cannabis reform has generally increased over time since the institution first started tracking public opinion on legalization in 2013, with 67 percent of voters now backing the policy change. That’s 17 percentage points higher than the 2013 results. Democrats are the most likely to favor legalizing cannabis, at 88 percent, followed by independents (79 percent). However, a majority of Republicans (56 percent) said they’re still opposed to adult-use legalization. Underscoring the importance of party control, the state’s Republican-controlled Senate and Assembly this summer rejected another attempt to legalize marijuana, defeating amendments to budget legislation that would have ended prohibition in the state and established new medical and recreational cannabis programs. Evers has routinely attempted to change that policy as part of his budget requests—and Democratic leaders have similarly pushed for reform. Republicans in the legislature also cut the marijuana provisions from a state budget proposal in May, as they’ve done in past sessions. Despite Republicans’ move to cut legalization from the budget legislation, party leaders recently acknowledged that the debate over medical marijuana legalization is “not going to go away,” and there’s hope it can be resolved this session. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — “I don’t think anyone is naive enough to think that marijuana and THC products aren’t present in the state of Wisconsin when they are readily available over state lines, so I think we need to come to an answer on this,” Assembly Majority Leader Rep. Tyler August (R) said in February. “I’m hopeful that we can.” “If we’re going to call it medical marijuana, it needs to be treated like a pharmaceutical. But the marijuana debate is going to be something that is not going to go away,” Sen. Dan Feyen (R), the assistant majority leader, said at the time. “The margins are tighter.” There have been repeated attempts to legalize medical marijuana in the legislature over recent years, including the introduction of legislation from Assembly Speaker Robin Vos (R) that called for a limited program facilitated through state-run dispensaries. That proved controversial among his Republican colleagues, however, and it ultimately stalled out last year. Evers previewed his plan to include marijuana legalization in his budget in January, while also arguing that residents of the state should be allowed to propose new laws by putting binding questions on the ballot—citing the fact that issues such as cannabis reform enjoy sizable bipartisan support while the GOP-controlled legislature has repeatedly refused to act. Previously, in 2022, the governor signed an executive order to convene a special legislative session with the specific goal of giving people the right to put citizen initiatives on the ballot, raising hopes among advocates that cannabis legalization could eventually be decided by voters. The GOP legislature did not adopt the proposal, however. Evers said in December that marijuana reform is one of several key priorities the state should pursue in the 2025 session, as lawmakers work with a budget surplus. Days after he made the remarks, a survey found the reform would be welcomed by voters in rural parts of the state. Nearly two thirds (65 percent) said they support legalizing cannabis. Last May, the governor said he was “hopeful” that the November 2024 election would lead to Democratic control of the legislature, in part because he argued it would position the state to finally legalize cannabis. “We’ve been working hard over the last five years, several budgets, to make that happen,” he said at the time. “I know we’re surrounded by states with recreational marijuana, and we’re going to continue to do it.” A Wisconsin Democratic Assemblymember tried to force a vote on a medical cannabis compromise proposal last year, as an amendment to an unrelated kratom bill, but he told Marijuana Moment he suspects leadership intentionally pulled that legislation from the agenda at the last minute to avoid a showdown on the issue. Meanwhile, the state Department of Revenue released a fiscal estimate of the economic impact of a legalization bill from then-Sen. Melissa Agard (D) in 2023, projecting that the reform would generate nearly $170 million annually in tax revenue. A legislative analysis requested by lawmakers estimated that Wisconsin residents spent more than $121 million on cannabis in Illinois alone in 2022, contributing $36 million in tax revenue to the neighboring state. Evers and other Democrats have since at least last January insisted that they would be willing to enact a modest medical marijuana program, even if they’d prefer more comprehensive reform. The post Wisconsin’s GOP Senate President Files New Medical Marijuana Legalization Bill appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net